secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tyra Biosciences, Inc. (TYRA)
CIK:        0001863127
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001193125-26-140027
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tyra Biosciences designates VP Finance Julia Rueb as principal accounting officer
--------------------------------------------------------------------------------

- Julia Rueb (VP Finance) appointed principal accounting officer effective April 1, 2026, succeeding CFO Alan Fuhrman.
- Fuhrman continues as principal financial officer; Rueb has been with the company since 2022.
- Rueb is a CPA with prior roles at SOAProjects and Ernst & Young; no family ties to directors or officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1863127/000119312526140027/0001193125-26-140027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1863127/000119312526140027/d136343d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-140027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer